Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease
It is well established that diabetes is the major cause of chronic kidney disease worldwide. Both hyperglycemia, and more recently, advanced glycation endproducts, have been shown to play critical roles in the development of kidney disease. Moreover, the renin-angiotensin system along with growth fa...
Main Authors: | Anna M. D. Watson, Eleanor A. M. Gould, Sarah C. Moody, Priyadharshini Sivakumaran, Karly C. Sourris, Bryna S. M. Chow, Audrey Koïtka-Weber, Terri J. Allen, Karin A. M. Jandeleit-Dahm, Mark E. Cooper, Anna C. Calkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2020.00518/full |
Similar Items
-
Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species
by: Anna M. D. Watson, et al.
Published: (2019-04-01) -
Endothelial reactive oxygen-forming NADPH oxidase 5 is a possible player in diabetic aortic aneurysm but not atherosclerosis
by: Florence Ho, et al.
Published: (2022-07-01) -
Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes
by: Amelia Charlton, et al.
Published: (2020-12-01) -
The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
by: M. C. Thomas, et al.
Published: (2012-01-01) -
Sodium‐Glucose Co‐Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes‐Induced Atherosclerotic Plaque Instability
by: Yung‐Chih Chen, et al.
Published: (2022-01-01)